文献速递角膜与眼表疾病

局部糖酵解抑制恢复单纯疱疹性角膜炎MAVS相关抗病毒信号

Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究探讨局部糖酵解抑制能否恢复线粒体抗病毒信号(MAVS)相关先天抗病毒信号并改善单纯疱疹性角膜炎(HSK)结局。体外和体内实验显示HK2表达升高,HK2敲低或2-DG抑制减少HSV-1复制并激活TBK1/IRF3通路,局部2-DG改善小鼠角膜上皮完整性、减少病毒蛋白且疗效与阿昔洛韦相当。结论提示局部糖酵解抑制通过MAVS介导的I型干扰素信号增强角膜抗病毒防御。

要点

  • HSK模型中HK2表达升高,HK2敲低或2-DG抑制减少HSV-1复制。
  • HK2与MAVS蛋白存在相互作用,HK2抑制激活TBK1/IRF3通路。
  • 局部2-DG改善小鼠角膜上皮完整性并减少病毒蛋白,疗效与阿昔洛韦相当。

核心结论

  • 局部糖酵解抑制通过MAVS介导的I型IFN信号增强角膜抗病毒防御,控制HSV-1并减轻疾病。

研究设计与样本

  • 建立体外和体内HSV-1 McKrae株感染模型,用慢病毒构建稳定HK2敲低的人角膜上皮细胞系。
  • 通过WB、IF、ELISA、RT-PCR分析蛋白/mRNA水平,Co-IP确认蛋白相互作用,小鼠角膜经裂隙灯成像、IF和WB评估。

主要发现

  • HSK模型中检测到HK2表达升高。
  • HK2敲低或2-DG介导的抑制减少HSV-1复制(ICP0降低、ISG56升高)。
  • Co-IP确认HK2与MAVS蛋白相互作用,HK2抑制激活TBK1/IRF3通路。
  • 局部应用2-DG改善小鼠角膜上皮完整性、减少病毒蛋白(糖蛋白D、ICP0),疗效与阿昔洛韦相当。

关键数值与推荐

  • HK2敲低或2-DG抑制后HSV-1复制减少表现为ICP0降低、ISG56升高。
  • 局部2-DG在小鼠中疗效与阿昔洛韦相当。

临床怎么用

  • 提示HK2可作为HSK治疗靶点,支持代谢疗法用于HSK及眼部疱疹病毒感染。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Herpes simplex keratitis (HSK) is a leading cause of infectious corneal blindness. Host antiviral responses, particularly type I interferon (IFN) signaling, are impaired during corneal herpes simplex virus type 1 (HSV-1) infection, partly due to viral immune evasion and metabolic reprogramming. This study investigated if topical glycolysis inhibition restores mitochondrial antiviral signaling (MAVS)-associated innate antiviral signaling and improves HSK outcomes. METHODS: In vitro and in vivo infection models were established using the HSV-1 McKrae strain. A stable hexokinase 2 (HK2)-knockdown human corneal epithelial cell (HCEC) line was generated using lentivirus. Protein/mRNA levels were analyzed via western blot (WB), immunofluorescence (IF), enzyme linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (RT-PCR). Protein interactions were confirmed by co-immunoprecipitation (Co-IP). Murine corneal pathology and viral proteins were assessed by slit-lamp imaging, IF, and WB. RESULTS: Elevated HK2 expression was detected in HSK models. HK2 knockdown or 2-deoxy-d-glucose (2-DG)-mediated inhibition reduced HSV-1 replication (lower infected cell protein 0 [ICP0], higher interferon-stimulated gene 56 [ISG56]). Co-IP confirmed the interaction between HK2 and MAVS protein, and HK2 inhibition activated the TANK-binding kinase 1 (TBK1)/interferon regulatory factor 3 (IRF3) pathway. Topical application of 2-DG improved murine corneal epithelial integrity, reduced viral proteins (glycoprotein D, ICP0), and showed efficacy comparable to acyclovir. CONCLUSIONS: Topical glycolysis inhibition enhances corneal antiviral defenses via MAVS-mediated type I IFN signaling, controlling HSV-1 and alleviating disease. It reveals a novel corneal metabolism-antiviral immunity link, highlights HK2 as a therapeutic target for HSK, and supports metabolic therapies for HSK and ocular herpes virus infections.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Xu W, Liu H, Cheng Z, et al. Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis. Invest Ophthalmol Vis Sci. 2026. PMID: 42530913. doi:10.1167/iovs.67.8.63

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。